Professional Documents
Culture Documents
Influenza
Introduction
Influenza is an infectious disease in which new strains of the influenza virus are created through
constant mutations from one season to the next. It is responsible for the worst and deadliest outbreak of
infectious disease history-killing 3% of the world’s entire population (Short, Kedzierska, & van de Sandt,
2018). Belonging to the Orthomyxoviridae family (ortho, Greek for “straight, true, or aromatic ring”; myxo,
Greek for “mucus-referring to the virus's ability to attach to the mucoprotein on the cell surface”), a family of
single-stranded RNA viruses that makes up three main types: Influenzavirus A (Type A), Influenzavirus B
(Type B), and Influenzavirus C (Type C) (oed.com, 2019). Lethal and unpredictable, Influenza is a highly
contagious respiratory illness and more commonly known as the “flu” that spreads from direct contact through
the air particles or indirect contact with an infected surface. The flu is not the same as the common cold, even
though they are both a respiratory illness and have similar symptoms. The Influenza symptoms are more
intense and can lead to serious neurological, cardiac, respiratory, pregnancy, and musculoskeletal health
complications or even death. Approximately 5-20% of Americans experience flu-like symptoms of a high
fever, body aches, tiredness, and chills every year mostly around late fall, winter, and early spring (Duda and
Jelic, 2018).
There are two different types of Influenzas (pandemic and epidemic) that Public Health officials
constantly monitor and collect surveillance on based on the severity of the infection and the ease of spread. A
Pandemic Influenza is when a new flu virus emerges every few decades or so, causing a serious global
outbreak that affects the entire population making everyone susceptible to infection, disease and death without
having any possible immunity. While the Epidemic Influenza or the seasonal flu is the most common
developing infection among humans that produce significant medical complications and are generally not fatal
except with the elderly, young children, or people with autoimmune diseases.
Maxine Staszak
Types
Type A Influenza infects humans as well as several kinds of animals, including birds, pigs, horses, and
rats. Additionally, wild birds can act as a natural host for the Influenza A virus causing the avian or bird flu, an
infection spread quickly to other animals and humans. People diagnosed with Influenza A infection show an
acute onset fever (102-104oF), severe body aches and pains, exhaustion, inflammation of the mucous
membranes lining the inner layer of the respiratory tract, and a painful migraine (CDC.gov, 2019). Since there
is a continuous emergence of new virus variants, eradication of the Type A Influenza cannot occur, and prior
flu vaccinations are unable to prevent infection from the new strain.
When comparing the three types of Influenza, found on the CDC.org website, Influenza Type A is
considered the most dangerous due to the cause of widespread global outbreaks and increased risk for disease.
Influenza Type B is similar to Influenza Type A in its severity but differs with classification, host range, and
its potential to cause epidemics. Additionally, both Type A and Type B are always changing and creating new
strains from one flu season to the next, but Influenza A mutates faster since Influenza Type B strain of genetic
makeup takes longer to modify (Ghebrehewet, MacPherson & Ho, 2016). The slower modification rate affects
Influenza Type B’s outbreaks by making them less frequent during the flu season and hinders the possibility of
inhibit further infection. Each Influenza name must consist of Break down of the process in naming a Type A
Influenza virus. This can be shortened to
Influenza A subtype H3N2 and then further
the antigenic type (A, B, C), the host of origin (avian), shortened to A H3N2 (cdc.gov, 2019).
geographical origin (Denver), strain number (15), and year of isolation (2009) (cdc.gov, 2019). When naming
Type A Influenzas, they are further classified by subtype which is determined by which versions of the
hemagglutinin (HA) and neuraminidase (NA) proteins appear on the surface layer of the virus as well as strain
destination. There are 18 different subtypes for the HA protein representing the number, H1-H18 and 11
different NA subtypes, N1-N11 (cdc.gov, 2019). The image to the right shows an example of how a Type A
Transmission
The transmission Influenza is both direct and indirect. It can be transferred between an infected person
to a susceptible individual by direct transmission such as touching, kissing, or direct projection. Hirve,
Newman, Paget, Azziz-Baumgartner, Fitzner, Bhat, et al., believed that Influenza spread mainly through
droplets made when infected people coughed, sneezed, talked and these droplets landed directly in the mouth
or noses of people nearby or inhaled into their lungs. They also concluded that individuals were less likely to
be infected by indirect transmissions like touching a contaminated surface or object (doorknobs, faucets,
phones, tables, and toys) with the flu and then placing their hands on their mouth, nose, or eyes. This could be
because when droplets are dispensed into the air, they can spread up to one meter, anyone in the vicinity can
breathe the droplets in, plus once out of the host the influenza virus can remain infectious for about a week at
human body temperatures with lower temperatures increasing the survival time. Whereas when transferred
through indirect transmission the infected surface can live for only a few hours. Overcrowded areas like
Maxine Staszak
schools, nursing homes, airports, and cities can enhance transmission by making the infection spread faster and
Mutation
appears when the virus makes a slight difference when copying the
be infected by the flu and why flu vaccinations must be administrated at least every year to combat the current
On the other hand, an antigenic shift is a sudden, substantial change in the influenza A virus which
produces a new arrangement of HA and NA proteins. When the shift occurs, most people have little to no
protection against the new infection since the new influenza subtypes are either completely different from the
current strain, haven’t been seen in a very long time, or entirely new. During this time the new virus spreads
rapidly and is transmitted easily from one person to the next often creating a pandemic. There are two possible
mutation outcomes. Sandbulte, Spickler, Zaabel & Roth, explain that the first mutation virus shift takes place
when the natural host (a person or animal) is infected by two different subtypes of influenza viruses circulating
at the same time, for instance, the human subtype can infect humans and/or pigs while the duck subtype can
Maxine Staszak
infect ducks and/or pigs. When the pig becomes infected concurrently with both the human and duck influenza
subtypes, the strands of both viruses are reasserted inside the same infected pig cell. The researchers
rationalize that the new subtype becomes highly contagious and dangerous because it gained the capability to
use the new duck HA protein to block the body’s immune response so that the antibodies are unable to defend
against the new virus subtype foreign attack. Another possible mutation that can develop is the avian strain
evolving so that the avian virus can directly transmit from birds to humans without needing another species to
rearrange the genetic material of influenza strains. An example of the antigenic shift was the production of the
that even though we are better prepared than 100 years ago, doesn’t mean we are even close to being ready
for the new challenges that will impact the next influenza virus pandemic. They researched the factors
behind the Spanish flu and incorporated it with the new problems that could affect the severity of a future
outbreak like population demographic changes, antibiotic resistance, climate change, as well a virus-related,
host, and external factors. More examples and important current factors that they took into account is shown
References
Cdc.gov. (2019). Asian Lineage Avian Influenza A(H7N9) Virus| CDC. [online] Available at:
Dash, M., & Kumari, P. (2017). Influenza: An overview. Indian Journal of Microbiology Research, 4(3),
234-238.
Duda, RN, K. and Jelic, MD, S. (2018). Overview of Influenza A and B. [online] Verywell Health.
770484?utm_term=95983104497489232&utm_campaign=cmsocialposting_health&utm_timesta
Ghebrehewet, S., MacPherson, P., & Ho, A. (2016). Influenza. Retrieved from
https://www.bmj.com/content/355/bmj.i6258
https://www.bcm.edu/departments/molecular-virology-and-microbiology/emerging-infections-
and-biodefense/influenza-virus-flu
Hirve, S., Newman, L. P., Paget, J., Azziz-Baumgartner, E., Fitzner, J., Bhat, N., ... & Zhang, W. (2016).
Influenza seasonality in the tropics and subtropics–when to vaccinate?. PloS one, 11(4),
e0153003.
Maxine Staszak
Ikonen, N., Savolainen-Kopra, C., Enstone, J. E., Kulmala, I., Pasanen, P., Salmela, A., ... & Ruutu, P.
McAuley, J., Kedzierska, K., Brown, L., & Shanks, G. (2015). Host Immunological Factors Enhancing
Mortality of Young Adults during the 1918 Influenza Pandemic. Frontiers In Immunology,
Poovorawan, Y., Pyungporn, S., Prachayangprecha, S., & Makkoch, J. (2013). Global alert to avian
influenza virus infection: from H5N1 to H7N9. Pathogens and global health, 107(5), 217-23.
Sandbulte, M., Spickler, A., Zaabel, P., & Roth, J. (2015). Optimal Use of Vaccines for Control of
Short, K., Kedzierska, K., & van de Sandt, C. (2018). Back to the Future: Lessons Learned From the 1918
https://www.frontiersin.org/articles/10.3389/fcimb.2018.00343/full
Maxine Staszak